Myomo (MYO) 2025 Investor Day Transcript

Myomo (MYO) 2025 Investor Day Summary Company Overview - Myomo is focused on developing assistive technology for individuals with paralysis, particularly through their product, MyoPro, which is a myoelectric orthosis designed to help users regain movement in paralyzed arms [7][8][10]. Key Industry Insights - The company operates in the medical device industry, specifically within the orthotics and prosthetics sector, addressing a significant unmet need for patients with chronic arm paralysis [7][8]. - Myomo has established a direct provider business model, which allows them to bring their products directly to patients, enhancing accessibility and support [8][9]. Financial Performance and Goals - Myomo aims to achieve $100 million in revenue by 2028, building on a decade of consistent revenue growth [10]. - The company reported a gross margin of 70%, with potential for improvement as they scale operations [8]. Market Position and Strategy - Myomo has a first-mover advantage in the myoelectric orthosis market, particularly after receiving CMS reimbursement, which opens the market to Medicare-age patients in the U.S. [8][9]. - The revenue breakdown for Q1 indicates that 79% of revenue came from direct billing, 3% from the VA, and 13% from international sales, with plans to grow the O&P clinical channel [9][10]. Marketing and Lead Generation - The marketing strategy includes TV advertising, digital marketing, and clinical referrals, with a focus on reducing the cost per pipeline acquisition [31][32]. - The company utilizes a call center in Fort Worth, Texas, to handle inbound and outbound calls, aiming to efficiently convert leads into patients [56][60]. Patient Journey and Fulfillment Process - The patient journey begins with lead generation, followed by telehealth screenings to assess eligibility, and then moves to the fulfillment stage where custom devices are fabricated [19][25][94]. - The fulfillment process is complex, requiring precise measurements and customization for each patient, which is critical for the effectiveness of the MyoPro device [97][98]. Challenges and Considerations - The company faces challenges related to patient eligibility, as not all patients qualify for the MyoPro due to varying clinical conditions [69][70]. - There is a need for continuous education and awareness among patients, therapists, and physicians to ensure proper understanding and utilization of the MyoPro [22][23]. Leadership and Team Structure - The leadership team includes experienced professionals from various backgrounds, emphasizing a commitment to patient care and innovative solutions [11][12]. - The company is structured to allow for efficient scaling of operations, particularly in the intake and telehealth screening processes [63][66]. Conclusion - Myomo is well-positioned to capitalize on the growing demand for assistive technologies for individuals with paralysis, with a clear strategy for growth and a strong focus on patient outcomes and satisfaction [7][10].